Navigation Links
New oral antiviral treatment of cold sores approved

A supplemental new drug application (sNDA) for Valtrex (valacyclovir HCl) caplets has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of cold sores in healthy adults. This was announced by GlaxoSmithKline which also added that this new application for Valtrex// makes it the first one-day, oral antiviral medication proven to shorten the duration of a cold sore outbreak.

Cold sores, also known as herpes labialis and commonly referred to as fever blisters, are ulcers or blisters on the lip and outer edges of the mouth caused by the herpes simplex virus. People who develop cold sores are advised to exercise high levels of caution, like washing hands immediately after touching the sore, as they are highly contagious, like other herpes infections. Though, it is estimated that that 20 to 40 per cent of adults develop cold sores at some point in time, it is not clear as to why some people get cold sores while others do not. Several factors like stress, exposure to sun, a cold, fever or flu could trigger the herpes simplex virus, which starts reproducing almost immediately, causing damage to skin cells that could lead to characteristic blisters.

Valtrex, is now, the only drug which offers the convenience of a one-day treatment for cold sores. It is also the only drug which offers the convenience of once-daily dosing for the suppression of genital herpes outbreaks, as well as a three-day treatment for recurrent outbreaks of genital herpes. Treatment with Valtrex is most effective when it is initiated at the first instance of a cold sore and should be administered for more than a day. The efficacy of using Valtrex for treatment after the development of clinical signs of a cold sore has, however, not yet been established.


'"/>




Page: 1

Related medicine news :

1. Catechins in green tea show antiviral effect on influenza virus
2. Thyroid hormone treatment hastens recovery after cardiac surgery
3. Feeding channel created by malaria parasite - a new target for malaria treatments
4. Now umbilical cord helps in stroke treatment.
5. Now AIDS treatment comes dirt-cheap
6. Breast cancer treatment to be determined by gene test
7. Hemopurifier may revolutionise AIDS treatment
8. New drug helps boost cancer treatment
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Experimental treatment for Ebola Virus Shows promising results in mice
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... ... August 23, 2017 , ... TSC Advantage has been ... Risk Management Solution Innovations and Security Solution for Government Innovations. Both gold awards ... and its DHS SAFETY Act-designated enterprise security assessment approach. , The ninth annual ...
(Date:8/23/2017)... ... August 23, 2017 , ... The non-profit ... holding an inaugural State of the Science Symposium in partnership with the Global ... 2017. , This symposium provides a forum for global leaders in human nutrition ...
(Date:8/22/2017)... ... August 22, 2017 , ... The Women’s Choice Award, a ... Migraine Relief with the 2017 Women’s Choice Award. The identification by women of an ... out of 4 migraine sufferers are women. In a survey taken by the Women’s ...
(Date:8/22/2017)... ... August 22, 2017 , ... Western ... spoke at a popular international aesthetics conference for medical professionals about the positive ... patients’ health and his growing practice. , Dr. George K. Ibrahim ...
(Date:8/22/2017)... ... August 22, 2017 , ... Each of the past six years, Lightning Labels has sent ... these labels and stickers, demonstrating the variety and creativity of their designs. Submissions this year ... came in. Now, it's time to announce the winners of the sixth annual Photo Contest, ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... president, effective Aug. 7, 2017. ... other interests and will serve as president emeritus during a ... us in multiple leadership roles since he joined Diplomat with ... has provided decisive, strategic leadership which continues to benefit our ...
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
(Date:8/4/2017)... 3, 2017  Agragen, LLC, a ... the biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces ... lead drug candidates, AGR131.  This drug is designed ... the blood of patients suffering from inflammatory conditions ... disease. Biological ...
Breaking Medicine Technology: